カテゴリ： QYResearch, 世界, 医療/バイオ

プロプラノロールの世界市場2023年：経口、注射

■ 英語タイトル：Global Propranolol Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7537）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7537
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[プロプラノロールの世界市場2023年：経口、注射]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はプロプラノロールのグローバル市場について調査・分析し、世界のプロプラノロール市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（経口、注射）、用途別セグメント分析（不整脈、高血圧、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentivaなどが含まれています。プロプラノロールのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、プロプラノロール市場規模を算出する際に考慮しました。

・プロプラノロール市場の概要
- 製品の定義
- プロプラノロールの種類別セグメント
- 世界のプロプラノロール市場規模：タイプ別分析（経口、注射）
- プロプラノロールの用途別セグメント
- 世界のプロプラノロール市場規模：用途別分析（不整脈、高血圧、その他）
- 世界のプロプラノロール市場規模予測（2018年-2029年）
- プロプラノロールの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- プロプラノロール市場の競争状況およびトレンド

・プロプラノロールの地域別市場規模
- 北米のプロプラノロール市場規模（2018年-2029年）
- 米国のプロプラノロール市場規模（2018年-2029年）
- ヨーロッパのプロプラノロール市場規模（2018年-2029年）
- アジア太平洋のプロプラノロール市場規模（2018年-2029年）
- 中国のプロプラノロール市場規模（2018年-2029年）
- 日本のプロプラノロール市場規模（2018年-2029年）
- 韓国のプロプラノロール市場規模（2018年-2029年）
- インドのプロプラノロール市場規模（2018年-2029年）
- オーストラリアのプロプラノロール市場規模（2018年-2029年）
- 中南米のプロプラノロール市場規模（2018年-2029年）
- 中東・アフリカのプロプラノロール市場規模（2018年-2029年）

・種類別セグメント：経口、注射
- 世界のプロプラノロールのタイプ別販売量（2018年-2023年）
- 世界のプロプラノロールのタイプ別売上（2018年-2023年）
- 世界のプロプラノロールのタイプ別価格

・用途別セグメント：不整脈、高血圧、その他
- 世界のプロプラノロールの用途別販売量（2018年-2023年）
- 世界のプロプラノロールの用途別売上（2018年-2023年）
- 世界のプロプラノロールの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Apotex、Teva、Atnas Pharma、AstraZeneca、Mylan、Novartis、Sanofi、Yabang Pharma、Sawai Seiyaku、ABZ-Pharma、Towa Yakuhin、Zydus Pharma、Nichi-Iko Pharmaceutical、Intas Pharma、IFET、Iqfarma、Zentiva

・産業チェーンと販売チャネルの分析
- プロプラノロール産業チェーン分析
- プロプラノロールの主要原材料
- プロプラノロールの販売チャネル
- プロプラノロールのディストリビューター
- プロプラノロールの主要顧客

・プロプラノロール市場ダイナミクス
- プロプラノロールの業界動向
- プロプラノロール市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Highlights
The global Propranolol market was valued at US$ 386 million in 2022 and is anticipated to reach US$ 477.8 million by 2029, witnessing a CAGR of 3.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.
Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Propranolol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propranolol.
The Propranolol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Propranolol market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propranolol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Segment by Type
Oral
Injection
Segment by Application
Arrhythmia
Hypertension
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Propranolol market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Propranolol and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Propranolol industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propranolol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Propranolol Market Overview
1.1 Product Overview and Scope of Propranolol
1.2 Propranolol Segment by Type
1.2.1 Global Propranolol Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Injection
1.3 Propranolol Segment by Application
1.3.1 Global Propranolol Market Value by Application: (2023-2029)
1.3.2 Arrhythmia
1.3.3 Hypertension
1.3.4 Others
1.4 Global Propranolol Market Size Estimates and Forecasts
1.4.1 Global Propranolol Revenue 2018-2029
1.4.2 Global Propranolol Sales 2018-2029
1.4.3 Global Propranolol Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Propranolol Market Competition by Manufacturers
2.1 Global Propranolol Sales Market Share by Manufacturers (2018-2023)
2.2 Global Propranolol Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Propranolol Average Price by Manufacturers (2018-2023)
2.4 Global Propranolol Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Propranolol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Propranolol, Product Type & Application
2.7 Propranolol Market Competitive Situation and Trends
2.7.1 Propranolol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Propranolol Players Market Share by Revenue
2.7.3 Global Propranolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Propranolol Retrospective Market Scenario by Region
3.1 Global Propranolol Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Propranolol Global Propranolol Sales by Region: 2018-2029
3.2.1 Global Propranolol Sales by Region: 2018-2023
3.2.2 Global Propranolol Sales by Region: 2024-2029
3.3 Global Propranolol Global Propranolol Revenue by Region: 2018-2029
3.3.1 Global Propranolol Revenue by Region: 2018-2023
3.3.2 Global Propranolol Revenue by Region: 2024-2029
3.4 North America Propranolol Market Facts & Figures by Country
3.4.1 North America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Propranolol Sales by Country (2018-2029)
3.4.3 North America Propranolol Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Propranolol Market Facts & Figures by Country
3.5.1 Europe Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Propranolol Sales by Country (2018-2029)
3.5.3 Europe Propranolol Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Propranolol Market Facts & Figures by Country
3.6.1 Asia Pacific Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Propranolol Sales by Country (2018-2029)
3.6.3 Asia Pacific Propranolol Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Propranolol Market Facts & Figures by Country
3.7.1 Latin America Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Propranolol Sales by Country (2018-2029)
3.7.3 Latin America Propranolol Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Propranolol Market Facts & Figures by Country
3.8.1 Middle East and Africa Propranolol Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Propranolol Sales by Country (2018-2029)
3.8.3 Middle East and Africa Propranolol Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Propranolol Sales by Type (2018-2029)
4.1.1 Global Propranolol Sales by Type (2018-2023)
4.1.2 Global Propranolol Sales by Type (2024-2029)
4.1.3 Global Propranolol Sales Market Share by Type (2018-2029)
4.2 Global Propranolol Revenue by Type (2018-2029)
4.2.1 Global Propranolol Revenue by Type (2018-2023)
4.2.2 Global Propranolol Revenue by Type (2024-2029)
4.2.3 Global Propranolol Revenue Market Share by Type (2018-2029)
4.3 Global Propranolol Price by Type (2018-2029)
5 Segment by Application
5.1 Global Propranolol Sales by Application (2018-2029)
5.1.1 Global Propranolol Sales by Application (2018-2023)
5.1.2 Global Propranolol Sales by Application (2024-2029)
5.1.3 Global Propranolol Sales Market Share by Application (2018-2029)
5.2 Global Propranolol Revenue by Application (2018-2029)
5.2.1 Global Propranolol Revenue by Application (2018-2023)
5.2.2 Global Propranolol Revenue by Application (2024-2029)
5.2.3 Global Propranolol Revenue Market Share by Application (2018-2029)
5.3 Global Propranolol Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Apotex
6.1.1 Apotex Corporation Information
6.1.2 Apotex Description and Business Overview
6.1.3 Apotex Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Apotex Propranolol Product Portfolio
6.1.5 Apotex Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Propranolol Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Atnas Pharma
6.3.1 Atnas Pharma Corporation Information
6.3.2 Atnas Pharma Description and Business Overview
6.3.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Atnas Pharma Propranolol Product Portfolio
6.3.5 Atnas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Propranolol Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Propranolol Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Propranolol Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Propranolol Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Yabang Pharma
6.8.1 Yabang Pharma Corporation Information
6.8.2 Yabang Pharma Description and Business Overview
6.8.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yabang Pharma Propranolol Product Portfolio
6.8.5 Yabang Pharma Recent Developments/Updates
6.9 Sawai Seiyaku
6.9.1 Sawai Seiyaku Corporation Information
6.9.2 Sawai Seiyaku Description and Business Overview
6.9.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sawai Seiyaku Propranolol Product Portfolio
6.9.5 Sawai Seiyaku Recent Developments/Updates
6.10 ABZ-Pharma
6.10.1 ABZ-Pharma Corporation Information
6.10.2 ABZ-Pharma Description and Business Overview
6.10.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABZ-Pharma Propranolol Product Portfolio
6.10.5 ABZ-Pharma Recent Developments/Updates
6.11 Towa Yakuhin
6.11.1 Towa Yakuhin Corporation Information
6.11.2 Towa Yakuhin Propranolol Description and Business Overview
6.11.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Towa Yakuhin Propranolol Product Portfolio
6.11.5 Towa Yakuhin Recent Developments/Updates
6.12 Zydus Pharma
6.12.1 Zydus Pharma Corporation Information
6.12.2 Zydus Pharma Propranolol Description and Business Overview
6.12.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zydus Pharma Propranolol Product Portfolio
6.12.5 Zydus Pharma Recent Developments/Updates
6.13 Nichi-Iko Pharmaceutical
6.13.1 Nichi-Iko Pharmaceutical Corporation Information
6.13.2 Nichi-Iko Pharmaceutical Propranolol Description and Business Overview
6.13.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio
6.13.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.14 Intas Pharma
6.14.1 Intas Pharma Corporation Information
6.14.2 Intas Pharma Propranolol Description and Business Overview
6.14.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Intas Pharma Propranolol Product Portfolio
6.14.5 Intas Pharma Recent Developments/Updates
6.15 IFET
6.15.1 IFET Corporation Information
6.15.2 IFET Propranolol Description and Business Overview
6.15.3 IFET Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.15.4 IFET Propranolol Product Portfolio
6.15.5 IFET Recent Developments/Updates
6.16 Iqfarma
6.16.1 Iqfarma Corporation Information
6.16.2 Iqfarma Propranolol Description and Business Overview
6.16.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iqfarma Propranolol Product Portfolio
6.16.5 Iqfarma Recent Developments/Updates
6.17 Zentiva
6.17.1 Zentiva Corporation Information
6.17.2 Zentiva Propranolol Description and Business Overview
6.17.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zentiva Propranolol Product Portfolio
6.17.5 Zentiva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Propranolol Industry Chain Analysis
7.2 Propranolol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Propranolol Production Mode & Process
7.4 Propranolol Sales and Marketing
7.4.1 Propranolol Sales Channels
7.4.2 Propranolol Distributors
7.5 Propranolol Customers
8 Propranolol Market Dynamics
8.1 Propranolol Industry Trends
8.2 Propranolol Market Drivers
8.3 Propranolol Market Challenges
8.4 Propranolol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Propranolol Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Propranolol Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Propranolol Market Competitive Situation by Manufacturers in 2022
Table 4. Global Propranolol Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Propranolol Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Propranolol Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Propranolol Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Propranolol Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Propranolol, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Propranolol, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Propranolol, Product Type & Application
Table 12. Global Key Manufacturers of Propranolol, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Propranolol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propranolol as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Propranolol Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Propranolol Sales by Region (2018-2023) & (K Units)
Table 18. Global Propranolol Sales Market Share by Region (2018-2023)
Table 19. Global Propranolol Sales by Region (2024-2029) & (K Units)
Table 20. Global Propranolol Sales Market Share by Region (2024-2029)
Table 21. Global Propranolol Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Propranolol Revenue Market Share by Region (2018-2023)
Table 23. Global Propranolol Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Propranolol Revenue Market Share by Region (2024-2029)
Table 25. North America Propranolol Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Propranolol Sales by Country (2018-2023) & (K Units)
Table 27. North America Propranolol Sales by Country (2024-2029) & (K Units)
Table 28. North America Propranolol Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Propranolol Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Propranolol Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Propranolol Sales by Country (2018-2023) & (K Units)
Table 32. Europe Propranolol Sales by Country (2024-2029) & (K Units)
Table 33. Europe Propranolol Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Propranolol Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Propranolol Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Propranolol Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Propranolol Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Propranolol Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Propranolol Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Propranolol Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Propranolol Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Propranolol Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Propranolol Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Propranolol Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Propranolol Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Propranolol Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Propranolol Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Propranolol Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Propranolol Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Propranolol Sales (K Units) by Type (2018-2023)
Table 51. Global Propranolol Sales (K Units) by Type (2024-2029)
Table 52. Global Propranolol Sales Market Share by Type (2018-2023)
Table 53. Global Propranolol Sales Market Share by Type (2024-2029)
Table 54. Global Propranolol Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Propranolol Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Propranolol Revenue Market Share by Type (2018-2023)
Table 57. Global Propranolol Revenue Market Share by Type (2024-2029)
Table 58. Global Propranolol Price (US$/Unit) by Type (2018-2023)
Table 59. Global Propranolol Price (US$/Unit) by Type (2024-2029)
Table 60. Global Propranolol Sales (K Units) by Application (2018-2023)
Table 61. Global Propranolol Sales (K Units) by Application (2024-2029)
Table 62. Global Propranolol Sales Market Share by Application (2018-2023)
Table 63. Global Propranolol Sales Market Share by Application (2024-2029)
Table 64. Global Propranolol Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Propranolol Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Propranolol Revenue Market Share by Application (2018-2023)
Table 67. Global Propranolol Revenue Market Share by Application (2024-2029)
Table 68. Global Propranolol Price (US$/Unit) by Application (2018-2023)
Table 69. Global Propranolol Price (US$/Unit) by Application (2024-2029)
Table 70. Apotex Corporation Information
Table 71. Apotex Description and Business Overview
Table 72. Apotex Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Apotex Propranolol Product
Table 74. Apotex Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Teva Propranolol Product
Table 79. Teva Recent Developments/Updates
Table 80. Atnas Pharma Corporation Information
Table 81. Atnas Pharma Description and Business Overview
Table 82. Atnas Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Atnas Pharma Propranolol Product
Table 84. Atnas Pharma Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Propranolol Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Mylan Propranolol Product
Table 94. Mylan Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Propranolol Product
Table 99. Novartis Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Propranolol Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Yabang Pharma Corporation Information
Table 106. Yabang Pharma Description and Business Overview
Table 107. Yabang Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Yabang Pharma Propranolol Product
Table 109. Yabang Pharma Recent Developments/Updates
Table 110. Sawai Seiyaku Corporation Information
Table 111. Sawai Seiyaku Description and Business Overview
Table 112. Sawai Seiyaku Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Sawai Seiyaku Propranolol Product
Table 114. Sawai Seiyaku Recent Developments/Updates
Table 115. ABZ-Pharma Corporation Information
Table 116. ABZ-Pharma Description and Business Overview
Table 117. ABZ-Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. ABZ-Pharma Propranolol Product
Table 119. ABZ-Pharma Recent Developments/Updates
Table 120. Towa Yakuhin Corporation Information
Table 121. Towa Yakuhin Description and Business Overview
Table 122. Towa Yakuhin Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Towa Yakuhin Propranolol Product
Table 124. Towa Yakuhin Recent Developments/Updates
Table 125. Zydus Pharma Corporation Information
Table 126. Zydus Pharma Description and Business Overview
Table 127. Zydus Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Zydus Pharma Propranolol Product
Table 129. Zydus Pharma Recent Developments/Updates
Table 130. Nichi-Iko Pharmaceutical Corporation Information
Table 131. Nichi-Iko Pharmaceutical Description and Business Overview
Table 132. Nichi-Iko Pharmaceutical Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Nichi-Iko Pharmaceutical Propranolol Product
Table 134. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 135. Intas Pharma Corporation Information
Table 136. Intas Pharma Description and Business Overview
Table 137. Intas Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Intas Pharma Propranolol Product
Table 139. Intas Pharma Recent Developments/Updates
Table 140. IFET Corporation Information
Table 141. IFET Description and Business Overview
Table 142. IFET Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. IFET Propranolol Product
Table 144. IFET Recent Developments/Updates
Table 145. Iqfarma Corporation Information
Table 146. Iqfarma Description and Business Overview
Table 147. Iqfarma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Iqfarma Propranolol Product
Table 149. Iqfarma Recent Developments/Updates
Table 150. Zentiva Corporation Information
Table 151. Zentiva Description and Business Overview
Table 152. Zentiva Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Zentiva Propranolol Product
Table 154. Zentiva Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Propranolol Distributors List
Table 158. Propranolol Customers List
Table 159. Propranolol Market Trends
Table 160. Propranolol Market Drivers
Table 161. Propranolol Market Challenges
Table 162. Propranolol Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Propranolol
Figure 2. Global Propranolol Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Propranolol Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Propranolol Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Propranolol Market Share by Application in 2022 & 2029
Figure 8. Arrhythmia
Figure 9. Hypertension
Figure 10. Others
Figure 11. Global Propranolol Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Propranolol Market Size (2018-2029) & (US$ Million)
Figure 13. Global Propranolol Sales (2018-2029) & (K Units)
Figure 14. Global Propranolol Average Price (US$/Unit) & (2018-2029)
Figure 15. Propranolol Report Years Considered
Figure 16. Propranolol Sales Share by Manufacturers in 2022
Figure 17. Global Propranolol Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Propranolol Players: Market Share by Revenue in 2022
Figure 19. Propranolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Propranolol Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Propranolol Sales Market Share by Country (2018-2029)
Figure 22. North America Propranolol Revenue Market Share by Country (2018-2029)
Figure 23. United States Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Propranolol Sales Market Share by Country (2018-2029)
Figure 26. Europe Propranolol Revenue Market Share by Country (2018-2029)
Figure 27. Germany Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Propranolol Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Propranolol Revenue Market Share by Region (2018-2029)
Figure 34. China Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Propranolol Sales Market Share by Country (2018-2029)
Figure 44. Latin America Propranolol Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Colombia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Propranolol Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Propranolol Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Propranolol Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Propranolol by Type (2018-2029)
Figure 55. Global Revenue Market Share of Propranolol by Type (2018-2029)
Figure 56. Global Propranolol Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Propranolol by Application (2018-2029)
Figure 58. Global Revenue Market Share of Propranolol by Application (2018-2029)
Figure 59. Global Propranolol Price (US$/Unit) by Application (2018-2029)
Figure 60. Propranolol Value Chain
Figure 61. Propranolol Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医薬品用グルコン酸カルシウムの世界市場2023年：注射剤、経口剤
  • 半固体投与剤の世界市場2023年：軟膏、ペースト、絆創膏、ジェル
  • トラゾドン塩酸塩錠の世界市場2023年：50mg、100mg、150mg、300mg
  • セフィキシム分散錠の世界市場2023年：50mg、100mg、200mg
  • 非動物性ソフトジェルカプセルの世界市場2023年：植物多糖類ソフトカプセル、澱粉ソフトカプセル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7537 )"プロプラノロールの世界市場2023年：経口、注射" (英文：Global Propranolol Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。